ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 12, 2020 09:00 JST
Source:
Injective Protocol
WOOTRADE Announces Strategic Partnership with Injective Protocol
DeFi Futures Exchange Injective Protocol Works Together with WOOTRADE to Increase DeFi Adoption
NEW YORK, NY, Jun 12, 2020 - (ACN Newswire) - Injective Protocol officially announces a strategic partnership with WOOTRADE, a leading digital asset dark pool, to combine resources to focus on increasing user adoption in the Decentralized Exchanges (DEX) space. The collaboration will bring together a series of initiatives such as implementing liquidity management, designing crypto asset derivative products and markets, and establishing an international corporate brand.
Decentralized Exchanges (DEX) are one of the most widely talked about topics in Decentralized Finance (DeFi). It is often considered to be the inevitable next evolution of digital asset exchanges due to addressing the growing problems with centralized exchanges such as the lack of transparency in transactions and frequent loss of assets due to hacking or becoming victims to social engineering.
Injective Protocol is a decentralized layer-2 peer-to-peer protocol that aims to enable fast and secure perpetual swaps, futures, leverage and spot transactions on Ethereum. The partnership will facilitate the transaction by leveraging WOOTRADE's transaction depth of 100 BTC with a spread of 0.05%. This liquidity stems from the in-depth aggregation of major exchanges, and the support of quantitative investment research institution Kronos Research for market-making strategies. Kronos has a daily transaction volume of $1 billion. In order to provide sufficient liquidity, WOOTRADE will also provide a low rate of 0% for connected exchanges, which saves hedge costs for exchanges. All in all, this collaborative effort will lead to a paradigm shift in the DeFi world.
WOOTRADE was incubated by Kronos Research, a leading quantitative investment research institution, and is funded by distributed capital from DFund, SNZ, Hashkey, as well as vector capital investment. The dark pool has a team that brings extensive experience in trading crypto assets and secondary assets. The top institutional trader has the technical expertise to manage high-level crypto market derivative products. Injective Protocol's derivatives protocol and technology-driven ecology can provide institutional traders, such as Kronos Research, with the ideal environment and conditions for the fastest, safest and most fair service for its markets and products.
About Injective Protocol
Founded in 2018, Injective Protocol is a fully decentralized, front-running proof layer-2 decentralized exchange. The protocol is based on the Cosmos-SDK and Ethereum network that integrates a verifiable delay function (VDF) to prevent transaction fraud and front-running. Along with early incubation by Binance Labs, they have received support from other top-tier international investment firms.
For More Information:
Website:
http://www.injectiveprotocol.com
.
Twitter:
https://twitter.com/InjectiveLabs
Medium:
http://medium.com/injective-labs/
Telegram:
https://t.me/joininjective
Press Contact:
hello@magicfew.com
Source: Injective Protocol
Sectors: Exchanges & Software, Crypto, Exchange, Blockchain Technology
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
Honda Unveils Next-generation EV Series for China
Apr 17, 2024 12:15 JST
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST
Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST
More Latest Release >>
Related Release
Injective Protocol Raises $2.6M For Decentralized Derivatives Exchange Protocol
July 29 2020 11:00 JST
More Press release >>